Associate Director - Medical Education Portfolio Lead at Eli Lilly and Company

Ontario, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in life sciences or healthcare; advanced degree (MBA, MSc, PharmD, MD, PhD) strongly preferred
7–10 years’ experience in Medical Affairs

Responsibilities

Define and implement the Canadian Medical Education (MedEd) strategy, aligned with global and affiliate priorities
Anticipate emerging educational needs by engaging with HCPs, medical societies, policy makers, and payers
Integrate innovative learning models (digital, hybrid, experiential) to increase reach, impact, and measurable outcomes
Lead the development, delivery, and evaluation of the national MedEd portfolio across therapeutic areas
Ensure timely, compliant, and impactful execution of programs, aligned to scientific priorities and unmet medical needs
Establish and track KPIs to measure educational effectiveness, HCP engagement, and downstream impact on patient care
Build and maintain trusted relationships with external stakeholders (societies, hospitals, academic centers, accreditation bodies, IMC, and Health Canada policy influencers)
Represent the company in external forums, shaping policy and advancing standards in continuing health education
Partner with external experts, thought leaders, and technology providers to co-create cutting-edge educational offerings
Partner with Business Units, Medical Affairs, and Global MedEd teams to ensure alignment and resource allocation
Actively contribute to affiliate leadership discussions, providing input into strategy, lifecycle management, and capability building
Drive shared learning and synergies across therapeutic areas and regional/global networks
Lead, mentor, and directly manage a team of medical education professionals, with responsibility for their performance, development, and succession planning
Build a culture of innovation, accountability, and continuous improvement
Recruit, onboard, and develop talent to strengthen functional expertise and ensure long-term organizational capability
Oversee financial stewardship of a multi-million-dollar budget, ensuring transparent allocation and ROI
Ensure programs comply with industry codes (IMC, CME guidelines, legal/E&C;) and align with best practices in adult learning
Optimize processes, tools, and frameworks to enable scalability, efficiency, and knowledge sharing

Skills

Medical Education

Strategic Planning

Portfolio Management

Team Leadership

Stakeholder Engagement

HCP Engagement

Digital Learning

Hybrid Learning

Experiential Learning

Program Evaluation

Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free